"Dr. Yahia Lodi attended medical school at Mymensingh Medical College and completed his residency at the Medical College of Wisconsin and Winnebago Mental Health Institute in Winnebago, WI. He also received fellowships at Johns Hopkins Hospital in Baltimore, NY, SUNY Buffalo, and Wayne State University in Detroit, MI. Dr. Lodi specializes in endovascular surgical neuroradiology, neuro endovascular, neurocritical care and vascular neurology. He is board certified by the American Board of Psychiatry and Neurology in general and vascular neurology, and by UCNS Certification in Neurocritical Care. Dr. Yahia Lodi has over 32 years of experience, and is affiliated with United Health Services Neuro-Inverventional Surgery in Johnson City, NY."

During the past decade, Southern New York Neurosurgical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southern New York Neurosurgical Group" are "Degenerative Disc Disease" (2 trials), "Chronic Pain" (1 trials) and "Degeneration of Lumbar Intervertebral Disc" (1 trials). Many other conditions were trialed in "Southern New York Neurosurgical Group" in a lesser frequency.

Most popular intervention types in "Southern New York Neurosurgical Group" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Avenue® L Interbody Fusion System (LDR Spine)" (1 trials), "BSC approved SCS Trial Therapy w/ OMG" (1 trials), "Non Boston Scientific SCS Trial Therapy" (1 trials), "NuBac" (1 trials) and "Prodisc-L" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern New York Neurosurgical Group" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Southern New York Neurosurgical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Southern New York Neurosurgical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southern New York Neurosurgical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".